glp-1 shortage news today november 2025 Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market Alarming rise in weight loss

To maximise benefits, consider forms that offer better absorption, such as liposomal or sublingual glutathione

More focused at work

Nutr Res Rev 2021 Dec;34(2):259-275

Many patients notice improved skin clarity and energy within a few weeks

Overall, about one in five (22%) adults who are not currently taking GLP-1 drugs (88% of the public) say they would be interested in taking a GLP-1 drug to lose weight, including just 7% who say they would be very interested. This rises to four in ten (43%) among adults who are not currently taking a GLP-1 but report being diagnosed as overweight or obese in the past five years, and about one in four (27%) among those who say they have been diagnosed with diabetes or heart disease

This vitamin-like compound supports the body in processing fats effectively while also aiding in mood regulation and combating insulin resistance